BLRX.TA | BioLineRx Ltd. Annual & Quarterly Balance Sheets

Annual Balance Sheets

(In USD)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	63.92 Million	76.38 Million	81.39 Million	47.29 Million	53.56 Million	56.23 Million
Total Current Assets	47.18 Million	52 Million	57.4 Million	22.88 Million	28.21 Million	31.97 Million
Cash And Short Term Investments	42.99 Million	51.08 Million	57.13 Million	22.58 Million	27.48 Million	30.15 Million
Cash and Cash Equivalents	4.25 Million	10.58 Million	12.99 Million	16.83 Million	5.29 Million	3.4 Million
Short Term Investments	38.73 Million	40.49 Million	44.14 Million	5.75 Million	22.19 Million	26.74 Million
Net Receivables	708 Thousand	721 Thousand	142 Thousand	141 Thousand	613 Thousand	1.33 Million
Inventory	1.95 Million	197.08 Thousand	126.73 Thousand	151.7 Thousand	107.27 Thousand	-
Other Current Assets	1.52 Million	919.00	269.00	293.00	721.00	488 Thousand
Total Non-Current Assets	16.74 Million	24.38 Million	23.98 Million	24.41 Million	25.35 Million	24.25 Million
Net PPE	1.88 Million	2.49 Million	2.28 Million	2.69 Million	3.46 Million	2.22 Million
Good Will And Intangible Assets	14.85 Million	21.88 Million	21.7 Million	21.71 Million	21.89 Million	21.97 Million
Good Will	-	-	-	-	-	-
Intangible Assets	14.85 Million	21.88 Million	21.7 Million	21.71 Million	21.89 Million	21.97 Million
Long-Term Investments	-	-	-	-	-	-
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	-	-	-	-	-	56 Thousand
Other Assets	-	-	-	-	-	-
Total Liabilities	50.7 Million	25.54 Million	13.3 Million	25.26 Million	20.18 Million	14.91 Million
Total Current Liabilities	30.85 Million	10.67 Million	9.71 Million	10.64 Million	11.96 Million	6.75 Million
Account Payables	10.86 Million	6.96 Million	5.56 Million	5.91 Million	7.79 Million	4.49 Million
Tax Payables	-	-	-	-	-	-
Short Term Debt	3.67 Million	1.96 Million	2.92 Million	3.28 Million	2.89 Million	895 Thousand
Deferred Revenue	12.95 Million	-	-	-	1.27 Million	1.34 Million
Other Current Liabilities	3.35 Million	1.74 Million	1.22 Million	1.44 Million	7000.00	14 Thousand
Total Non Current Liabilities	19.85 Million	14.86 Million	3.58 Million	14.61 Million	8.21 Million	8.16 Million
Long-Term Debt	7.91 Million	10.35 Million	1.72 Million	4.4 Million	7.56 Million	7.83 Million
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	11.93 Million	4.5 Million	1.85 Million	10.21 Million	658 Thousand	323 Thousand
Other Liabilities	-	-	-	-	-	-
Total Equity	13.22 Million	50.84 Million	68.08 Million	22.03 Million	33.38 Million	41.32 Million
Stock Holders Equity	13.22 Million	50.84 Million	68.08 Million	22.03 Million	33.38 Million	41.32 Million
Common Stock	31.35 Million	27.1 Million	21.06 Million	9.87 Million	4.69 Million	3.11 Million
Retained Earnings	-390.6 Million	-329.99 Million	-305.04 Million	-277.98 Million	-247.96 Million	-222.52 Million
Accumulated other comprehensive income	15.58 Million	13.34 Million	11.74 Million	10.9 Million	10.71 Million	10.53 Million
Common Stock Equity	13.22 Million	50.84 Million	68.08 Million	22.03 Million	33.38 Million	41.32 Million
Capital Lease Obligation	1.81 Million	2.15 Million	1.89 Million	1.85 Million	1.96 Million	-
Total Investments	38.73 Million	40.49 Million	44.14 Million	5.75 Million	22.19 Million	26.74 Million
Total Debt	11.59 Million	12.32 Million	4.65 Million	7.68 Million	10.45 Million	8.73 Million
Net Debt	7.33 Million	1.73 Million	-8.33 Million	-9.14 Million	5.15 Million	5.32 Million

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2
Total Assets	64.59 Million	51.6 Million	63.92 Million	63.92 Million	52.85 Million	58.93 Million
Total Current Assets	49.11 Million	35.69 Million	47.18 Million	47.18 Million	28.8 Million	34.69 Million
Cash And Short Term Investments	40.06 Million	28.17 Million	42.99 Million	42.99 Million	25.96 Million	32.81 Million
Cash and Cash Equivalents	9.62 Million	5.99 Million	4.25 Million	4.25 Million	7.72 Million	10.1 Million
Short Term Investments	30.43 Million	22.18 Million	38.73 Million	38.73 Million	18.24 Million	22.71 Million
Net Receivables	3.83 Million	3.33 Million	708 Thousand	708 Thousand	315 Thousand	128 Thousand
Inventory	3.63 Million	2.88 Million	1.95 Million	1.95 Million	1.35 Million	1.74 Million
Other Current Assets	1.58 Million	1.29 Million	1.52 Million	1.52 Million	1.17 Million	1877.00
Total Non-Current Assets	15.48 Million	15.9 Million	16.74 Million	16.74 Million	24.05 Million	24.24 Million
Net PPE	1.79 Million	1.71 Million	1.88 Million	1.88 Million	2.02 Million	2.23 Million
Good Will And Intangible Assets	13.69 Million	14.19 Million	14.85 Million	14.85 Million	22.02 Million	22.01 Million
Good Will	-	-	-	-	-	21.99 Million
Intangible Assets	13.69 Million	14.19 Million	14.85 Million	14.85 Million	22.02 Million	22.01 Thousand
Long-Term Investments	-	-	-	-	-	-
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	-	-	-	-	-	-
Other Assets	-	-	-	-	-	-
Total Liabilities	50.61 Million	38.54 Million	50.7 Million	50.7 Million	39.72 Million	37.88 Million
Total Current Liabilities	30.51 Million	31.37 Million	30.85 Million	30.85 Million	14.72 Million	12.44 Million
Account Payables	6.26 Million	8.25 Million	10.86 Million	10.86 Million	8.43 Million	6.73 Million
Tax Payables	-	-	-	-	-	-
Short Term Debt	11.15 Million	4.14 Million	3.67 Million	3.67 Million	3.6 Million	3.45 Million
Deferred Revenue	5.47 Million	9.02 Million	12.95 Million	12.95 Million	-	-
Other Current Liabilities	7.61 Million	9.94 Million	3.35 Million	3.35 Million	2.68 Million	2.26 Million
Total Non Current Liabilities	20.09 Million	7.16 Million	19.85 Million	19.85 Million	24.99 Million	25.43 Million
Long-Term Debt	20.09 Million	7.16 Million	7.91 Million	7.91 Million	9.7 Million	10.08 Million
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	-	-	11.93 Million	11.93 Million	15.28 Million	15.35 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	13.98 Million	13.06 Million	13.22 Million	13.22 Million	13.13 Million	21.05 Million
Stock Holders Equity	13.98 Million	13.06 Million	13.22 Million	13.22 Million	13.13 Million	21.05 Million
Common Stock	34.41 Million	31.35 Million	31.35 Million	31.35 Million	28.33 Million	27.1 Million
Retained Earnings	-390.81 Million	-391.3 Million	-390.6 Million	-390.6 Million	-376.72 Million	-360.69 Million
Accumulated other comprehensive income	16.55 Million	16.11 Million	15.58 Million	15.58 Million	14.65 Million	14.2 Million
Common Stock Equity	13.98 Million	13.06 Million	13.22 Million	13.22 Million	13.13 Million	21.05 Million
Capital Lease Obligation	1.8 Million	1.69 Million	1.81 Million	1.81 Million	1.77 Million	1.96 Million
Total Investments	30.43 Million	22.18 Million	38.73 Million	38.73 Million	18.24 Million	22.71 Million
Total Debt	31.25 Million	11.31 Million	11.59 Million	11.59 Million	13.31 Million	13.53 Million
Net Debt	21.63 Million	5.32 Million	7.33 Million	7.33 Million	5.58 Million	3.43 Million

Balance Sheet Charts

Immunocore Holdings plc

IMCR

Full Analysis

Annual Balance Sheets
Loop Telecommunication International,Inc.

3025

Full Analysis

Annual Balance Sheets
The Lion Electric Company

LEV

Full Analysis

Annual Balance Sheets
Analyst I.M.S. Investment Management Services Ltd

ANLT

Full Analysis

Annual Balance Sheets
Gold Mountain Limited

GMN

Full Analysis

Annual Balance Sheets
Shenzhen Weiguang Biological Products Co., Ltd.

002880

Full Analysis

Annual Balance Sheets

Global Stocks Search

BioLineRx Ltd. (BLRX.TA)

Annual Balance Sheets

Balance Sheet Charts

Immunocore Holdings plc

Loop Telecommunication International,Inc.

The Lion Electric Company

Analyst I.M.S. Investment Management Services Ltd

Gold Mountain Limited

Shenzhen Weiguang Biological Products Co., Ltd.